155 related articles for article (PubMed ID: 1301071)
1. Reductive metabolism of diaziquone (AZQ) in the S9 fraction of MCF-7 cells. II. Enhancement of the alkylating activity of AZQ by NAD(P)H: quinone-acceptor oxidoreductase (DT-diaphorase).
Fisher GR; Donis J; Gutierrez PL
Biochem Pharmacol; 1992 Oct; 44(8):1625-35. PubMed ID: 1301071
[TBL] [Abstract][Full Text] [Related]
2. The reductive metabolism of diaziquone (AZQ) in the S9 fraction of MCF-7 cells: free radical formation and NAD(P)H: quinone-acceptor oxidoreductase (DT-diaphorase) activity.
Fisher GR; Gutierrez PL
Free Radic Biol Med; 1991; 10(6):359-70. PubMed ID: 1654286
[TBL] [Abstract][Full Text] [Related]
3. Free radical formation and DNA strand breakage during metabolism of diaziquone by NAD(P)H quinone-acceptor oxidoreductase (DT-diaphorase) and NADPH cytochrome c reductase.
Fisher GR; Gutierrez PL
Free Radic Biol Med; 1991; 11(6):597-607. PubMed ID: 1663902
[TBL] [Abstract][Full Text] [Related]
4. Metabolism of diaziquone by NAD(P)H:(quinone acceptor) oxidoreductase (DT-diaphorase): role in diaziquone-induced DNA damage and cytotoxicity in human colon carcinoma cells.
Siegel D; Gibson NW; Preusch PC; Ross D
Cancer Res; 1990 Nov; 50(22):7293-300. PubMed ID: 2121335
[TBL] [Abstract][Full Text] [Related]
5. Thiol oxidation coupled to DT-diaphorase-catalysed reduction of diaziquone. Reductive and oxidative pathways of diaziquone semiquinone modulated by glutathione and superoxide dismutase.
Ordoñez ID; Cadenas E
Biochem J; 1992 Sep; 286 ( Pt 2)(Pt 2):481-90. PubMed ID: 1530580
[TBL] [Abstract][Full Text] [Related]
6. Activation and deactivation of quinones catalyzed by DT-diaphorase. Evidence for bioreductive activation of diaziquone (AZQ) in human tumor cells and detoxification of benzene metabolites in bone marrow stroma.
Ross D; Siegel D; Gibson NW; Pacheco D; Thomas DJ; Reasor M; Wierda D
Free Radic Res Commun; 1990; 8(4-6):373-81. PubMed ID: 2113030
[TBL] [Abstract][Full Text] [Related]
7. Reductive activation of diaziquone and possible involvement of free radicals and the hydroquinone dianion.
Gutierrez PL; Biswal S; Nardino R; Biswal N
Cancer Res; 1986 Nov; 46(11):5779-85. PubMed ID: 3019536
[TBL] [Abstract][Full Text] [Related]
8. The role of NAD(P)H:quinone oxidoreductase in quinone-mediated p21 induction in human colon carcinoma cells.
Qiu XB; Cadenas E
Arch Biochem Biophys; 1997 Oct; 346(2):241-51. PubMed ID: 9343371
[TBL] [Abstract][Full Text] [Related]
9. The effect of functional groups on reduction and activation of quinone bioreductive agents by DT-diaphorase.
Fourie J; Oleschuk CJ; Guziec F; Guziec L; Fiterman DJ; Monterrosa C; Begleiter A
Cancer Chemother Pharmacol; 2002 Feb; 49(2):101-10. PubMed ID: 11862423
[TBL] [Abstract][Full Text] [Related]
10. Induction of p53 by the concerted actions of aziridine and quinone moieties of diaziquone.
Ngo EO; Nutter LM; Sura T; Gutierrez PL
Chem Res Toxicol; 1998 Apr; 11(4):360-8. PubMed ID: 9548807
[TBL] [Abstract][Full Text] [Related]
11. A comparison of free radical formation by quinone antitumour agents in MCF-7 cells and the role of NAD(P)H (quinone-acceptor) oxidoreductase (DT-diaphorase).
Fisher GR; Patterson LH; Gutierrez PL
Chem Biol Interact; 1993 Sep; 88(2-3):137-53. PubMed ID: 8403076
[TBL] [Abstract][Full Text] [Related]
12. Structure-activity relationships for DT-diaphorase reduction of hypoxic cell directed agents: indoloquinones and diaziridinyl benzoquinones.
Bailey SM; Suggett N; Walton MI; Workman P
Int J Radiat Oncol Biol Phys; 1992; 22(4):649-53. PubMed ID: 1544832
[TBL] [Abstract][Full Text] [Related]
13. Mechanism(s) of bioreductive activation. The example of diaziquone (AZQ).
Gutierrez PL
Free Radic Biol Med; 1989; 6(4):405-45. PubMed ID: 2651223
[TBL] [Abstract][Full Text] [Related]
14. Alteration in DNA cross-linking and sequence selectivity of a series of aziridinylbenzoquinones after enzymatic reduction by DT-diaphorase.
Lee CS; Hartley JA; Berardini MD; Butler J; Siegel D; Ross D; Gibson NW
Biochemistry; 1992 Mar; 31(11):3019-25. PubMed ID: 1372518
[TBL] [Abstract][Full Text] [Related]
15. Relationship between DT-diaphorase-mediated metabolism of a series of aziridinylbenzoquinones and DNA damage and cytotoxicity.
Gibson NW; Hartley JA; Butler J; Siegel D; Ross D
Mol Pharmacol; 1992 Sep; 42(3):531-6. PubMed ID: 1406604
[TBL] [Abstract][Full Text] [Related]
16. The role of NAD(P)H: quinone reductase (EC 1.6.99.2, DT-diaphorase) in the reductive bioactivation of the novel indoloquinone antitumor agent EO9.
Walton MI; Smith PJ; Workman P
Cancer Commun; 1991 Jul; 3(7):199-206. PubMed ID: 1714284
[TBL] [Abstract][Full Text] [Related]
17. Induction of p21 mediated by reactive oxygen species formed during the metabolism of aziridinylbenzoquinones by HCT116 cells.
Qiu X; Forman HJ; Schönthal AH; Cadenas E
J Biol Chem; 1996 Dec; 271(50):31915-21. PubMed ID: 8943236
[TBL] [Abstract][Full Text] [Related]
18. Mechanism for the reductive activation of diaziquone.
Mossoba MM; Alizadeh M; Gutierrez PL
J Pharm Sci; 1985 Dec; 74(12):1249-54. PubMed ID: 4087189
[TBL] [Abstract][Full Text] [Related]
19. Mechanisms of DNA strand breakage and interstrand cross-linking by diaziridinylbenzoquinone (diaziquone) in isolated nuclei from human cells.
Szmigiero L; Kohn KW
Cancer Res; 1984 Oct; 44(10):4453-7. PubMed ID: 6467205
[TBL] [Abstract][Full Text] [Related]
20. Alkylation of DNA by the new anticancer agent 3,6-diaziridinyl-2,5-bis(carboethoxyamino)-1,4-benzoquinone (AZQ).
King CL; Wong SK; Loo TL
Eur J Cancer Clin Oncol; 1984 Feb; 20(2):261-4. PubMed ID: 6538490
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
